Carfilzomib in combination with lenalidomide and dexamethasone or carfilzomib in combination with dexamethasone alone in patients with multiple myeloma who have received at least one prior therapy: Interim results of the non-interventional CARO study. Knauf, W., Ammon, A., Merling, M., Hurtz, H.-J., Vannier, C., Schulz, H., Marschner, N., Riedt, T., Potthoff, K., 2018. Oncol Res Treat 41 (suppl 4)(P572). Download Does progression influence the quality of life? – Data from patients with advanced breast cancer from the MaLife-Project. Marschner N., Söling, U., Scholz, H., Azeh, I., Chiabudini, M., Kruggel, L., Jänicke, M., 2018. Oncol Res Treat 41 (suppl.4) (V493)… Weiterlesen An observational study to evaluate the effectiveness of OnLife® in improving chemotherapy-induced peripheral neuropathy in patients with colon or breast cancer after end of adjuvant therapy: Design of the STEFANO trial. Zaiss, M., Uhlig, J., Zahn, M.-O., Decker, T., Lehmann, H., Harde, J., Hogrefe, C., Vannier, C., Marschner, N., 2018. Oncol Res Treat 41 (suppl 4)(P945). Weiterlesen